Published in Eur J Med Res on September 29, 1997
Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol (2001) 1.85
Role of ERCP and therapeutic biliary endoscopy in association with laparoscopic cholecystectomy. Am J Gastroenterol (1992) 1.47
Sulfite-containing Canadian pharmaceutical products available in 1991. CMAJ (1992) 1.43
Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan. Cephalalgia (2004) 1.19
Gangliosides in nervous tissue cultures and binding of 125I-labelled tetanus toxin, a neuronal marker. J Neurochem (1977) 1.08
Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol (1994) 1.01
Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency. Transfus Med (2012) 0.94
Effect of the external nasal dilator Breathe Right on snoring. Eur J Med Res (1998) 0.91
Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats. Muscle Nerve (1995) 0.91
The influence of electromagnetic fields on human brain activity. Eur J Med Res (1995) 0.87
Binding characteristics of 125I-labelled tetanus toxin to primary tissue cultures from mouse embryonic CNS. J Neurochem (1977) 0.86
Effect of phospholipase C inhibitor U-73122 on antigen-induced airway smooth muscle contraction in guinea pigs. Am J Respir Cell Mol Biol (1993) 0.86
Quantitative EEG and BPRS data following Haldol-Decanoate administration in schizophrenics. Int Clin Psychopharmacol (1994) 0.85
Suppression of 3H-acetylcholine release from primary nerve cell cultures by tetanus and botulinum-A toxin. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.85
Relation between psychometric tests and quantitative topographic EEG in pharmacology. Int J Clin Pharmacol Ther Toxicol (1992) 0.81
Interaction of labelled tetanus toxin with substructures of rat spinal cord in vivo. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.81
Hyperexcitability of cultured central nervous system neurons caused by tetanus toxin. Exp Neurol (1979) 0.81
125I-Labelled tetanus toxin as a neuronal marker in tissue cultures derived from embryonic CNS. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.81
Pharmacodynamic effects of valerian and hops extract combination (Ze 91019) on the quantitative-topographical EEG in healthy volunteers. Eur J Med Res (2000) 0.80
Classification of drugs by stereotactic recording of focal brain activity in the rat (stereo-EEG). Neuropsychobiology (1984) 0.80
Radioelectroencephalography (Tele-Stereo-EEG) in the rat as a pharmacological model to differentiate the central action of flupirtine from that of opiates, diazepam and phenobarbital. Neuropsychobiology (1986) 0.80
Multiunit activity from the A9 and A10 areas in rats following chronic treatment with different neuroleptic drugs. Eur Neuropsychopharmacol (1994) 0.80
Reflection of mental exercise in the dynamic quantitative topographical EEG. Neuropsychobiology (1995) 0.80
Effect of gangliosides on nerve conduction velocity during diabetic neuropathy in the rat. Arch Int Pharmacodyn Ther (1987) 0.79
Pathophysiology and psychopharmacology of dementia--a new study design. I. Diagnosis comprising subjective and objective criteria. Neuropsychobiology (1995) 0.78
Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG. Pharmacopsychiatry (1998) 0.78
Changes in heart rate variability during induction of anesthesia with fentanyl and midazolam. J Cardiothorac Vasc Anesth (1996) 0.77
Kinetics of [3H]acetylcholine synthesis and release in primary cell cultures from mammalian CNS. J Neurochem (1978) 0.77
Electrophysiological studies on the effects of the neurotoxin apamin on cultured neurons. Adv Cytopharmacol (1979) 0.77
EEG-power spectral components of schizoaffective disorders. Schizophr Res (1991) 0.77
Distribution of 125 I-tetanus toxin and 125 I-toxoid in rats with generalized tetanus, as influenced by antitoxin. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.77
'Fingerprints' of central stimulatory drug effects by means of quantitative radioelectroencephalography in the rat (tele-stereo-EEG). Neuropsychobiology (1986) 0.76
Evidence for neuronal dysfunction in migraine: concurrence between specific qEEG findings and clinical drug response--a retrospective analysis-. Eur J Med Res (2000) 0.76
Normal and pseudorabies virus infected primary nerve cell cultures in scanning electron microscopy. Med Microbiol Immunol (1979) 0.76
Genetics of house flies. Variability studies with North Dakota, Texas, and Florida populations. J Hered (1975) 0.76
Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study. Funct Neurol (1995) 0.75
[Screening test for adsorbing agents suited for the extraction of biologically active vasopressin from plasma]. Pharmazie (1980) 0.75
Pathophysiology and psychopharmacology of dementia--a new study design. 2. Cyclandelate treatment--a placebo-controlled double-blind clinical trial. Neuropsychobiology (1997) 0.75
Morphological and electrophysiological aspects of dissociated cultures of rat CNS. Arch Toxicol (1983) 0.75
Mammalian nerve cell culture. Methods Enzymol (1981) 0.75
A new frequency based automatic sleep analysis - description of the healthy sleep. Eur J Med Res (1997) 0.75
[Left hemispheric site of EEG findings in patients with schizophrenic psychoses]. Fortschr Neurol Psychiatr (1990) 0.75
[A new method for assessment of mental performance during simultaneous, quantitative, topographical electroencephalometry and psychometry in pharmacology. Proof of the effect of a combination of biogenic amines, vitamins, minerals and trace elements]. Arzneimittelforschung (1994) 0.75
A field comparison of two strains of sterilized screwworm flies. J Med Entomol (1976) 0.75
Validation of an EEG-derived spectral frequency index (SFx) for continuous monitoring of sleep depth in humans. Eur J Med Res (1998) 0.75
Nervous system-specific protein D2 associated with neurite outgrowth in nerve cell cultures. J Neuroimmunol (1982) 0.75
Studies of gangliosides in diverse nerve cell cultures. Adv Exp Med Biol (1984) 0.75
[Effect of discontinuous hemorrhage on plasma and cerebrospinal fluid vasopressin concentration in anesthesized rabbits]. Acta Biol Med Ger (1981) 0.75
[Topographic changes in cerebral electric activity after premedication with flunitrazepam]. Anasthesiol Intensivmed Notfallmed Schmerzther (1994) 0.75
[Studies on the extraction of biologically active vasopressin from plasma (author's transl)]. Pharmazie (1981) 0.75
Description of healthy and disturbed sleep by means of the spectral frequency index (SFx) - a retrospective analysis. Eur J Med Res (2001) 0.75
Rat nerve cell cultures in pharmacology and toxicology. Arch Toxicol (1980) 0.75
Ganglioside therapy in experimental diabetic neuropathy. Arzneimittelforschung (1988) 0.75
Source density analysis of functional topographical EEG: monitoring of cognitive drug action. Eur J Med Res (1996) 0.75
Classification of sulpiride, clozapine and haloperidol by toposelective recording from different brain structures in the immobilized rat (stereo-EEG). Neuropsychobiology (1985) 0.75
Drug-induced field potential changes in dopaminergic target areas after electrical stimulation of the rat mesencephalon. Neuropsychobiology (1985) 0.75
[Local treatment of bacterial infections in surgical ambulatory practice using Fucidine-gel]. Z Allgemeinmed (1975) 0.75
[Neurotoxic actions of Clostridium tetani and botulinum toxins (proceedings)]. Zentralbl Bakteriol Orig A (1976) 0.75
Movement of labeled macromolecules to the goldfish optic tectum following intraocular injection of 125I-labelled tetanus toxin. Exp Neurol (1976) 0.75